H.R. 5160

119th Congress

Reported

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Sponsored byRepublican:Rep. Smith, Christopher H. [R-NJ-4]NJ· Introduced 4 septembre 2025
Open on Congress.gov

21

Cosponsors

18

Actions

0

Amendments

1

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

21 juillet 2026·2 days ago

Summary

Reported to House · Updated 16 juillet 2026

Stem Cell Therapeutic and Research Reauthorization Act of 2025

This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).

The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research.

Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Timeline

18 actions

  1. Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

    21 juillet 2026 · Calendars

  2. Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

    20 juillet 2026 · Floor

  3. DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.

    20 juillet 2026 · Floor

  4. Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

    20 juillet 2026 · Floor

  5. Considered under suspension of the rules.

    20 juillet 2026 · Floor

  6. Motion to reconsider laid on the table Agreed to without objection.

    20 juillet 2026 · Floor

  7. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    20 juillet 2026 · Floor

  8. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    20 juillet 2026 · Floor

  9. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

    2 juillet 2026 · Committee

  10. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

    2 juillet 2026 · Committee

  11. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

    2 juillet 2026 · Committee

  12. Placed on the Union Calendar, Calendar No. 629.

    2 juillet 2026 · Calendars

  13. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

    2 juillet 2026 · Committee

  14. Placed on the Union Calendar, Calendar No. 629.

    2 juillet 2026 · Calendars

  15. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

    2 juillet 2026 · Committee

  16. Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.

    21 mai 2026 · Committee

  17. Committee Consideration and Mark-up Session Held

    21 mai 2026 · Committee

  18. Committee Consideration and Mark-up Session Held

    21 mai 2026 · Committee

  19. Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.

    21 mai 2026 · Committee

  20. Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.

    21 mai 2026 · Committee

Sponsorship

21 cosponsors

Sponsor

Republican:Rep. Smith, Christopher H. [R-NJ-4]NJ

Cosponsors

  • Democrat1152%
  • Republican1048%

Classification

Policy area

Health

Legislative subjects

Biological and life sciencesBlood and blood diseasesCell biology and embryologyHealth programs administration and fundingOrgan and tissue donation and transplantation

Committees

1

  • Energy and Commerce Committee

    House · Standing

    • Referred To4 Sept 2025
    • Markup By21 May 2026

    • Health Subcommittee

      • Referred to4 Sept 2025
      • Markup by13 May 2026
      • Reported by13 May 2026

Reports

Cosponsor momentum

Cumulative over time

Cosponsors grew from 5 on 4 septembre 2025 to 21 on 29 mai 2026.

Pelosi Tracker
Follow on XRejoignez notre Discord
PolitiquesProjets de loiPortefeuillesTarifsÀ proposMentions légalesConditions d'utilisationPolitique de confidentialité
English
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.